KRAS Gene Mutation clinical trials at University of California Health
2 in progress, 0 open to eligible people
Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations
Sorry, in progress, not accepting new patients
This phase Ib trial studies the side effects of pembrolizumab and trametinib in treating patients with non-small cell lung cancer and KRAS gene mutations that has spread to other places in the body. Monoclonal antibodies, such as pembrolizumab, may…
at UC Davis
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer
Sorry, in progress, not accepting new patients
This phase II trial studies how well trametinib and docetaxel work in treating patients with stage IV KRAS mutation positive non-small cell lung cancer or cancer that has come back. Trametinib may stop the growth of tumor cells by blocking some of…
at UC Davis
Our lead scientists for KRAS Gene Mutation research studies include Jonathan Riess.
Last updated: